E-LIB Suche - Ergebnisse für: Boumendil, A

1

Autologous hematopoietic cell transplantation (autoHCT) for..:

Renders, S. ; Finel, H. ; Ngoya, M....
Hematological Oncology. 41 (2023) S2 - p. 447-447 , 2023

Link: https://doi.org/10.1002/..

2

Efficacy and toxicity of CAR T‐cell therapy in patients wit..:

Laube, A. ; Fuhrmann, S. ; Peczynski, C....
Hematological Oncology. 41 (2023) S2 - p. 454-456 , 2023

Link: https://doi.org/10.1002/..

3

Perforations cornéennes chez des patients traités par inhib..:

Amar, J. ; El Kaim, P. ; Scemla, B....
Journal Français d'Ophtalmologie. 46 (2023) 9 - p. 1111-1113 , 2023

Link: https://doi.org/10.1016/..

4

Prognostic factors for cellular therapies ‐ CART and alloge..:

Glass, B. ; Sureda, A. ; Boumendil, A....
Hematological Oncology. 41 (2023) S2 - p. 449-451 , 2023

Link: https://doi.org/10.1002/..

5

Combined Dermis Spacer Graft, Lateral Canthopexy and Subper..:

Keilani, C. ; Sahel, J.-A. ; Nordmann, J.-P..
Journal of Maxillofacial and Oral Surgery. , 2022

Link: https://doi.org/10.1007/..

6

Long‐term outcome of patients receiving haematopoietic allo..:

Gutiérrez‐García, G. ; Martínez, C. ; Boumendil, A....
British Journal of Haematology. 196 (2021) 4 - p. 1018-1030 , 2021

Link: https://doi.org/10.1111/..

7

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR PERIPHERA..:

Dreger, P. ; Ngoya, M. ; Litovich, C....
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

8

Durable benefit of rituximab maintenance post-autograft in ..:

Pettengell, R. ; Uddin, R. ; Boumendil, A....
Bone Marrow Transplantation. 56 (2021) 6 - p. 1413-1421 , 2021

Link: https://doi.org/10.1038/..

9

Outcome in patients with diffuse large B-cell lymphoma who ..:

González-Barca, E. ; Boumendil, A. ; Blaise, D....
Bone Marrow Transplantation. 55 (2019) 2 - p. 393-399 , 2019

Link: https://doi.org/10.1038/..

10

Autologous hematopoietic stem cell transplantation for rela..:

on behalf of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation ; Domingo-Domènech, E. ; Boumendil, A....
Bone Marrow Transplantation. 55 (2019) 4 - p. 796-803 , 2019

Link: https://doi.org/10.1038/..

11

DONOR LYMPHOCYTE INFUSIONS INDUCE DURABLE RESPONSES IN PATI..:

Robinson, S. ; Boumendil, A. ; Finel, H....
Hematological Oncology. 37 (2019) S2 - p. 316-317 , 2019

Link: https://doi.org/10.1002/..

12

Effectiveness and safety comparison of three eye and orbita..:

Keilani, C. ; Baus, A. ; Tick, S...
Annales de Chirurgie Plastique Esthétique. 64 (2019) 4 - p. 351-361 , 2019

Link: https://doi.org/10.1016/..

13

Allogeneic hematopoietic stem cell transplantation for pati..:

on behalf of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation ; Domingo-Domènech, E. ; Boumendil, A....
Bone Marrow Transplantation. 55 (2019) 3 - p. 633-640 , 2019

Link: https://doi.org/10.1038/..

14

THE EFFICACY OF IBRUTINIB IN PATIENTS WITH RELAPSED MANTLE ..:

Burney, C.N. ; Robinson, S. ; Boumendil, A....
Hematological Oncology. 37 (2019) S2 - p. 243-244 , 2019

Link: https://doi.org/10.1002/..

15

HOW TO SELECT DONOR, STEM CELL SOURCE, AND CONDITIONING REG..:

Bazarbachi, A. ; Boumendil, A. ; Finel, H....
Hematological Oncology. 37 (2019) S2 - p. 299-300 , 2019

Link: https://doi.org/10.1002/..